Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection

Stroke Clinical Trial

— ACTIV4  

Official title:

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05226416
• Other study ID #: ACTIV4
• Status: Completed
• Start date: February 21, 2022
• Est. completion date: April 21, 2023

Study information

• Verified date: May 2023
• Source: Eurasian Association of Therapists
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Depersonalized multi-centered registry initiated to analyze dynamics of non-infectious diseases after SARS-CoV-2 infection in population of Eurasian adult patients.

Description:

Assessment of hospital course and health status during 3, 6, 12 months after discharge in COVID-19 patients in cohorts with comorbidities and without comorbidities. Evaluation of comorbidity impact to severity of novel coronavirus disease and comorbidity impact to demand for medical care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3554
• Est. completion date: April 21, 2023
• Est. primary completion date: March 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Suspected or confirmed COVID-19

Exclusion Criteria:

• Age under 18 years.
• Refusal to be involved in study;

Related Conditions & MeSH terms

• Anemia
• Arrythmia
• Asthma
• Atrial Fibrillation
• Chronic Heart Failure
• Chronic Kidney Diseases
• Copd
• Coronary Artery Disease
• COVID-19
• Diabetes Mellitus
• DVT
• Embolism
• Heart Diseases
• Heart Failure
• Hypertensive Heart Disease
• Ischemia
• Ischemic Heart Disease
• Ischemic Stroke
• Kidney Diseases
• Myocardial Infarction
• Myocardial Ischemia
• Myocarditis
• Oncology
• Overweight
• Overweight and Obesity
• Pulmonary Embolism
• Renal Insufficiency, Chronic
• Stroke

Locations

Country	Name	City	State
Russian Federation	Eurasian Association of Therapists	Moscow

Sponsors (1)

Lead Sponsor	Collaborator
Eurasian Association of Therapists

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	death for any cause	rate of lethal outcomes	From date of hospitalization until the date of first documented date of death from any cause, assessed up to 12 months
Primary	hospitalization for any cause	rate of hospitalization for any cause	12 months after discharge
Secondary	onset of any disease diagnosed 1 year after discharge	rate of patients with onset of any disease diagnosed 1 year after discharge	1 year after discharge
Secondary	rate of demand for medical care	number of patients seeking for health care after discharge	1 year after discharge